This is an educational meeting that has been funded and organized by Ipsen Biopharma. For healthcare professionals only.

Join our expert faculty of geneticists and adult and pediatric hepatologists
in two interactive virtual meetings, where they will explore how the use of genetic testing can advance the diagnosis and management of pediatric and adult patients with genetic cholestatic diseases - with a focus on interpreting genetic test results.

Once registration is complete, you will receive a confirmation email. The virtual meeting will take place on Zoom. Prior to the event, a personalized link to join the meeting will be shared with you.

As places are limited, and to ensure you can benefit from the full program, attendance at both meetings is mandatory.


17:00 – 17:10

Welcome to Meeting 1

17:10 – 18:05

Plenary Part 1

Understanding genetic testing methods

Plenary Part 2

‘How to’ guide for understanding genetic testing reports

18:05 – 18:25

Q&A

18:25 – 18:40

Break

18:40 – 19:40

Plenary Part 1

Understanding key genes in genetic cholestasis: Focus on ATP8B1, ABCB4 and ABCB11
The pediatric perspective and the adult perspective

Plenary Part 2

Understanding key genes in genetic cholestasis: Focus on JAG1, NOTCH 2 and TJP2
The pediatric perspective and the adult perspective

19:40 – 19:55

Q&A

19:55 - 20:00

Summary and close

17:00 – 17:15

Welcome to Meeting 2 and key highlights from Meeting 1

17:15 – 17:45

Workshop

Case-based session: Interpreting 3 genetic test reports

Group 1: Pediatric cases
Group 2: Adult cases

17:45 – 18:10

Plenary

When to suspect genetic cholestatic liver disease

18:10 – 18:20

Q&A

18:20 – 18:40

Break

18:40 – 19:00

Plenary

Implications of genetic testing results on the management of cholestatic liver disease

19:00 – 19:30

Workshop

Case-based session: How diagnostic test results impact patient management decisions

Group 1: Pediatric cases
Group 2: Adult cases

19:30 – 19:50

Panel discussion

Tips and tricks for managing patients with genetic cholestatic liver disease

19:50 – 20:00

Summary and close